E Rødevand

1.4k total citations
29 papers, 1.0k citations indexed

About

E Rødevand is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, E Rødevand has authored 29 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Rheumatology, 9 papers in Immunology and 8 papers in Hematology. Recurrent topics in E Rødevand's work include Rheumatoid Arthritis Research and Therapies (18 papers), Spondyloarthritis Studies and Treatments (14 papers) and Autoimmune and Inflammatory Disorders Research (8 papers). E Rødevand is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (18 papers), Spondyloarthritis Studies and Treatments (14 papers) and Autoimmune and Inflammatory Disorders Research (8 papers). E Rødevand collaborates with scholars based in Norway, Netherlands and United Kingdom. E Rødevand's co-authors include K. Mikkelsen, C. Kaufmann, Tore K Kvien, Wenche Koldingsnes, E. Lie, S. Kary, Marte Schrumpf Heiberg, H. Küpper, Peter Holck and Martina Kron and has published in prestigious journals such as Annals of the Rheumatic Diseases, Lara D. Veeken and Scandinavian Journal of Rheumatology.

In The Last Decade

E Rødevand

25 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E Rødevand Norway 14 852 468 340 142 63 29 1.0k
Ana M. Bertoli United States 16 921 1.1× 460 1.0× 59 0.2× 117 0.8× 175 2.8× 40 1.1k
G. Guettrot-Imbert France 11 377 0.4× 135 0.3× 63 0.2× 59 0.4× 55 0.9× 35 536
Chengappa Kavadichanda India 13 231 0.3× 112 0.2× 80 0.2× 41 0.3× 50 0.8× 62 521
Berkan Armağan Türkiye 13 208 0.2× 172 0.4× 103 0.3× 21 0.1× 62 1.0× 116 602
C. Kaufmann Norway 16 883 1.0× 538 1.1× 327 1.0× 9 0.1× 63 1.0× 18 1.1k
İsmail Şimşek Türkiye 15 258 0.3× 91 0.2× 111 0.3× 310 2.2× 48 0.8× 49 677
Ediz Dalkılıç Türkiye 11 224 0.3× 148 0.3× 84 0.2× 22 0.2× 43 0.7× 72 494
Aatke van der Maas Netherlands 15 678 0.8× 277 0.6× 233 0.7× 11 0.1× 95 1.5× 46 817
Anabela Barcelos Portugal 13 389 0.5× 208 0.4× 124 0.4× 9 0.1× 81 1.3× 73 588
Christopher C. Striebich United States 10 361 0.4× 212 0.5× 74 0.2× 23 0.2× 62 1.0× 20 647

Countries citing papers authored by E Rødevand

Since Specialization
Citations

This map shows the geographic impact of E Rødevand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Rødevand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Rødevand more than expected).

Fields of papers citing papers by E Rødevand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E Rødevand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Rødevand. The network helps show where E Rødevand may publish in the future.

Co-authorship network of co-authors of E Rødevand

This figure shows the co-authorship network connecting the top 25 collaborators of E Rødevand. A scholar is included among the top collaborators of E Rødevand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E Rødevand. E Rødevand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Haugeberg, Glenn, Gunnstein Bakland, E Rødevand, et al.. (2021). POS0612 EXPLORING EQUIVALENCE BETWEEN BIOSIMILAR SB4 AND REFERENCE ETANERCEPT BY ASSESSING EFFECTIVENESS IN RHEUMATOID ARTHRITIS PATIENTS TREATED IN ORDINARY CLINICAL PRACTICE. Annals of the Rheumatic Diseases. 80. 543–543. 1 indexed citations
2.
Haavardsholm, Espen A., Anna‐Birgitte Aga, Inge Christoffer Olsen, et al.. (2015). Aiming for Remission in Rheumatoid Arthritis : Clinical and Radiographic Outcomes from a Randomized Controlled Strategy Trial Investigating the Added Value of Ultrasonography in a Treat-to-Target Regimen. Data Archiving and Networked Services (DANS). 67. 4 indexed citations
3.
Fagerli, K. M., Elisabeth Lie, Désirée van der Heijde, et al.. (2013). The role of methotrexate co-medication in TNF-inhibitor treatment in patients with psoriatic arthritis: results from 440 patients included in the NOR-DMARD study. Annals of the Rheumatic Diseases. 73(1). 132–137. 131 indexed citations
4.
Fagerli, K. M., E. Lie, Désirée van der Heijde, et al.. (2012). Selecting patients with ankylosing spondylitis for TNF inhibitor therapy: comparison of ASDAS and BASDAI eligibility criteria. Lara D. Veeken. 51(8). 1479–1483. 31 indexed citations
5.
Fagerli, K. M., E. Lie, Désirée van der Heijde, et al.. (2011). Predictors of ASDAS Major Improvement in Patients with Ankylosing Spondylitis Receiving Their First TNF Inhibitor. Results From a Longitudinal Observational Study. Data Archiving and Networked Services (DANS). 63(10). 4 indexed citations
6.
Lie, E., D. van der Heijde, Till Uhlig, et al.. (2011). Treatment strategies in patients with rheumatoid arthritis for whom methotrexate monotherapy has failed: data from the NOR-DMARD register. Annals of the Rheumatic Diseases. 70(12). 2103–2110. 19 indexed citations
7.
Lie, E., Till Uhlig, D. van der Heijde, et al.. (2011). Effectiveness of sulfasalazine and methotrexate in 1102 DMARD-naive patients with early RA. Lara D. Veeken. 51(4). 670–678. 14 indexed citations
8.
Lie, E., Désirée van der Heijde, Till Uhlig, et al.. (2010). Effectiveness of switching between TNF inhibitors in ankylosing spondylitis: data from the NOR-DMARD register. Annals of the Rheumatic Diseases. 70(1). 157–163. 108 indexed citations
9.
Lie, E., D. van der Heijde, T. Uhlig, et al.. (2009). Effectiveness and retention rates of methotrexate in psoriatic arthritis in comparison with methotrexate-treated patients with rheumatoid arthritis. Annals of the Rheumatic Diseases. 69(4). 671–676. 88 indexed citations
10.
Nikolaisen, Cathrin, Tore K Kvien, K. Mikkelsen, et al.. (2009). Contemporary use of disease‐modifying drugs in the management of patients with early rheumatoid arthritis in Norway. Scandinavian Journal of Rheumatology. 38(4). 240–245. 15 indexed citations
11.
Bosch, Filip Van den, Bernhard Manger, Philippe Goupille, et al.. (2009). Effectiveness of adalimumab in treating patients with active psoriatic arthritis and predictors of good clinical responses for arthritis, skin and nail lesions. Annals of the Rheumatic Diseases. 69(2). 394–399. 100 indexed citations
12.
Milman, Nils, et al.. (2009). A novel mutation in theNOD2gene associated with Blau syndrome: a Norwegian family with four affected members. Scandinavian Journal of Rheumatology. 38(3). 190–197. 28 indexed citations
13.
Wallenius, Marianne, Johan F. Skomsvoll, Wenche Koldingsnes, et al.. (2008). Comparison of work disability and health‐related quality of life between males and females with rheumatoid arthritis below the age of 45 years. Scandinavian Journal of Rheumatology. 38(3). 178–183. 32 indexed citations
14.
Wallenius, Marianne, Johan F. Skomsvoll, Wenche Koldingsnes, et al.. (2008). Work disability and health-related quality of life in males and females with psoriatic arthritis. Annals of the Rheumatic Diseases. 68(5). 685–689. 72 indexed citations
15.
Rudwaleit, Martín, E Rødevand, Peter Holck, et al.. (2008). Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label study. Annals of the Rheumatic Diseases. 68(5). 696–701. 208 indexed citations
16.
Heiberg, Marte Schrumpf, C. Kaufmann, E Rødevand, et al.. (2007). The comparative effectiveness of anti-TNF therapy and methotrexate in patients with psoriatic arthritis: 6 month results from a longitudinal, observational, multicentre study. Annals of the Rheumatic Diseases. 66(8). 1038–1042. 59 indexed citations
17.
Rødevand, E, et al.. (2004). TAKAYASU ARTERITIS. Scandinavian Journal of Rheumatology. 33(2). 130–130.
18.
Rødevand, E, et al.. (2001). [Takayasu's arteritis].. PubMed. 121(2). 173–6. 2 indexed citations
19.
Rødevand, E, Jørn Bathen, & Monika Østensen. (1999). [Rheumatoid arthritis and heart disease].. PubMed. 119(2). 223–5. 2 indexed citations
20.
Rødevand, E, et al.. (1996). [Arthritis after BCG treatment of bladder cancer. A rare complication].. PubMed. 116(27). 3231–2. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ana M. Bertoli Breakdown of academic impact, for papers by G. Guettrot-Imbert Breakdown of academic impact, for papers by Chengappa Kavadichanda Breakdown of academic impact, for papers by Berkan Armağan Breakdown of academic impact, for papers by C. Kaufmann Breakdown of academic impact, for papers by İsmail Şimşek Breakdown of academic impact, for papers by Ediz Dalkılıç Breakdown of academic impact, for papers by Aatke van der Maas Breakdown of academic impact, for papers by Anabela Barcelos Breakdown of academic impact, for papers by Christopher C. Striebich
Rankless by CCL
2026